000 01231 a2200373 4500
005 20250513150709.0
264 0 _c19980903
008 199809s 0 0 eng d
022 _a0029-7844
024 7 _a10.1016/s0029-7844(98)00167-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPaavonen, J
245 0 0 _aCost-benefit analysis of first-void urine Chlamydia trachomatis screening program.
_h[electronic resource]
260 _bObstetrics and gynecology
_cAug 1998
300 _a292-8 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aChlamydia trachomatis
_xisolation & purification
650 0 4 _aCost-Benefit Analysis
650 0 4 _aDecision Trees
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMass Screening
_xeconomics
650 0 4 _aMiddle Aged
650 0 4 _aPolymerase Chain Reaction
650 0 4 _aSensitivity and Specificity
650 0 4 _aUrine
_xmicrobiology
700 1 _aPuolakkainen, M
700 1 _aPaukku, M
700 1 _aSintonen, H
773 0 _tObstetrics and gynecology
_gvol. 92
_gno. 2
_gp. 292-8
856 4 0 _uhttps://doi.org/10.1016/s0029-7844(98)00167-7
_zAvailable from publisher's website
999 _c9665396
_d9665396